MOLECULAR DIFFERENCES BETWEEN MYELOID LINEAGE NEOPLASMS (ACUTE MYELOID LEUKAEMIA, MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS) AND THEIR CLINICAL IMPLICATIONS

被引：0
|
作者：
Gonzalez, A. [1 ]
Alvarez, N. [1 ]
Morales, M. L. [1 ]
Carreno, G. [2 ]
Onecha, E. [1 ]
Sanchez, R. [1 ]
Espino, M. J. [2 ]
Tejero, F. [2 ]
Linares, M. [2 ]
Martinez, P. [1 ]
Cedena, T. [3 ]
Rapado, I [2 ]
Martinez-Lopez, J. [2 ]
Ayala, R. [1 ]
机构：
[1] Inst Invest Hosp 12 Octubre I 12, Unidad Invest Clin Tumores Hematol H12O CNIO, Dept Hematol Traslac, CIBERONC, Madrid, Spain
[2] Hosp 12 Octubre, Serv Hematol, Dept Hematol Traslac, Madrid, Spain
[3] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol, Madrid, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO-060
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [21] Abnormal B-lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia
    Chan, Alexander
    Kumar, Priyadarshini
    Gao, Qi
    Baik, Jeeyeon
    Sigler, Allison
    Londono, Dory
    Liu, Ying
    Arcila, Maria E.
    Dogan, Ahmet
    Zhang, Yanming
    Roshal, Mikhail
    Xiao, Wenbin
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (03) : 243 - 252
  • [22] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
    Scott, Lesley J.
    DRUGS, 2016, 76 (08) : 889 - 900
  • [23] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
    Lesley J. Scott
    Drugs, 2016, 76 : 889 - 900
  • [24] NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
    Forghieri, Fabio
    Paolini, Ambra
    Morselli, Monica
    Bigliardi, Sara
    Bonacorsi, Goretta
    Leonardi, Giovanna
    Coluccio, Valeria
    Maccaferri, Monica
    Fantuzzi, Valeria
    Faglioni, Laura
    Colaci, Elisabetta
    Soci, Francesco
    Nasillo, Vincenzo
    Messerotti, Andrea
    Arletti, Laura
    Pioli, Valeria
    Zucchini, Patrizia
    Quadrelli, Chiara
    Corradini, Giorgia
    Giacobbi, Francesca
    Vallerini, Daniela
    Riva, Giovanni
    Barozzi, Patrizia
    Lagreca, Ivana
    Marasca, Roberto
    Narni, Franco
    Mecucci, Cristina
    Ottaviani, Emanuela
    Martinelli, Giovanni
    Falini, Brunangelo
    Luppi, Mario
    Potenza, Leonardo
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3222 - 3226
  • [25] Lenalidomide/anthracyclines/alkylating-agentsAcute myeloid leukaemia and myelodysplastic neoplasms
    Reactions Weekly, 2024, 1999 (1) : 217 - 217
  • [26] Clonal Analysis of Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasms
    Ushijima, Yoko
    Ishikawa, Yuichi
    Hattori, Hikaru
    Kawashima, Naomi
    Fujiwara, Shun
    Terakura, Seitaro
    Sanada, Masashi
    Kiyoi, Hitoshi
    BLOOD, 2017, 130
  • [27] Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas
    Goasguen, Jean E.
    Bennett, John M.
    Bain, Barbara J.
    Brunning, Richard
    Vallespi, Maria-Teresa
    Tomonaga, Masao
    Zini, Gina
    Renault, Alain
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (04) : 526 - 533
  • [28] Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia
    Dores, Graca M.
    Linet, Martha S.
    Curtis, Rochelle E.
    Morton, Lindsay M.
    BLOOD, 2023, 141 (08) : 951 - 955
  • [29] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    Samantha O‘Hagan Henderson
    Jochen J. Frietsch
    Inken Hilgendorf
    Andreas Hochhaus
    Claus-Henning Köhne
    Jochen Casper
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2599 - 2609
  • [30] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    O'Hagan Henderson, Samantha
    Frietsch, Jochen J.
    Hilgendorf, Inken
    Hochhaus, Andreas
    Koehne, Claus-Henning
    Casper, Jochen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2599 - 2609
12345